Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Deazapurine Derivatives. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1771254A reveals a streamlined Mannich reaction for nucleoside phosphorylase inhibitors, offering significant cost reduction and scalable supply chain solutions for API manufacturing.
Patent CN114957262A details a Pd-catalyzed C-H activation method for deazapurines, offering high regioselectivity and mild conditions for scalable API intermediate production.